FMS
Fresenius Medical Care AG & Co. KGAA

664
Mkt Cap
$13.7B
Volume
255,063.00
52W High
$30.46
52W Low
$18.94
PE Ratio
22.07
FMS Fundamentals
Price
$27.09
Prev Close
$27.20
Open
$27.07
50D MA
$25.95
Beta
0.47
Avg. Volume
370,834.71
EPS (Annual)
$0.9915
P/B
1.02
Rev/Employee
$183,744.42
Loading...
Loading...
News
all
press releases
CVS vs. FMS: Which Healthcare Services Stock Has More Upside?
CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Zacks·4d ago
News Placeholder
Here's Why Fresenius (FMS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·13d ago
News Placeholder
FMS vs. OFIX: Which Stock Is the Better Value Option?
FMS vs. OFIX: Which Stock Is the Better Value Option?
Zacks·21d ago
News Placeholder
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·27d ago
News Placeholder
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·1mo ago
News Placeholder
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Zacks·1mo ago
News Placeholder
Are Options Traders Betting on a Big Move in Fresenius Medical Stock?
Investors need to pay close attention to FMS stock based on the movements in the options market lately.
Zacks·2mo ago
News Placeholder
Encompass Health Q2 Earnings Beat Estimates, Stock Up 7.4%
EHC posts strong Q2 with higher EPS, revenue growth, and a raised 2025 outlook, along with shares gaining 7.4%.
Zacks·3mo ago
News Placeholder
FMS vs. OFIX: Which Stock Should Value Investors Buy Now?
FMS vs. OFIX: Which Stock Is the Better Value Option?
Zacks·3mo ago

Latest FMS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.